Innate inflammation as the common pathway of risk factors leading to TIAs and stroke

Annals of the New York Academy of Sciences

Volumn 1207, Issue , 2010, Pages 8-10

  del Zoppo, Gregory J ^a,b   Gorelick, Philip B ^c  

^a Division of Hematology   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cognitive impairment Alzheimer's disease; Infection; Innate inflammation; Neurovascular unit; Stroke

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; INTEGRIN RECEPTOR; INTERLEUKIN 6; MEMBRANE RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BASEMENT MEMBRANE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; COGNITION; DEMENTIA; DISEASE COURSE; EDEMA; EXTRACELLULAR MATRIX; GINGIVITIS; HEART INFARCTION; HUMAN; IMMUNOTHERAPY; INFECTION PREVENTION; INFECTION RISK; INFLAMMATION; LABORATORY; MAST CELL; MICROGLIA; NEUROPATHOLOGY; PERICYTE; STROKE; T LYMPHOCYTE; TISSUE REACTION; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; ANIMAL; EDITORIAL; INNATE IMMUNITY; PATHOPHYSIOLOGY; RISK FACTOR;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; ISCHEMIC ATTACK, TRANSIENT; RISK FACTORS; STROKE;

EID: 78149236630     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05762.x     Document Type: Article

References (16)

1. del Zoppo, G.J. 2006. Perspective: stroke and neurovascular protection.N. Engl. J. Med. 354: 553-555.
2. del Zoppo, G.J. 2009. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience 158: 972-982.
3. delZoppo,G.J. 2009.Relationship of neurovascular elements to neuron injury during ischemia. Cerebrovasc. Dis. 27: 65-76.
4. Gorelick, P.B. 2002. Stroke prevention therapy beyond antithrombotics. Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. An invited review. Stroke 33: 862-875.
5. Elkind, M.S. et al. 2009. High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Neurology 73: 1300-1307.
6. Elkind, M.S. et al. 2010. Infectious burden and risk of stroke: the Northern Manhattan Study. Arch. Neurol. 67: 33-38.
7. O'Connor, C.M. et al. 2003. Azithromycin for the secondary prevention of coronary heart disease events. J. Am. Med. Assoc. 290: 1459-1466.
8. Cannon, C.P. et al. 2005. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N. Engl. J.Med. 352: 1646-1654.
9. Grayston, J.T. et al. 2005. Azithromycin for the secondary prevention of coronary events. N. Engl. J. Med. 352: 1637-1645.
10. Lavallee, P. et al. 2002. Association between influenza vaccination and reduced risk of brain infarction. Stroke 33: 513-518.
11. Gorelick, P.B. 2005. William M. Feinberg Lecture: Cognitive vitality and the role of stroke and cardiovascular disease risk factors. Stroke 36: 875-879.
12. Gorelick, P.B. 1999. Can we save the brain from the ravages of midlife cardiovascular risk factors? Neurology 52: 1114-1115.
13. Gorelick, P.B. et al. 1999. Prevention of vascular dementia. Alzheimer Dis. Assoc. Disord. 13(Suppl. 3): S131-S139.
14. Gorelick, P.B. 2010. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann. N.Y. Acad. Sci. 1207: 155-162.
15. Milner, R. et al. 2008. Responses of endothelial cell and astrocytematrix-integrin receptors to ischemia mimic those observed in the neurovascular unit. Stroke 39: 191-197.
16. Milner, R. et al. 2008. The rapid decrease in astrocyteassociated dystroglycan expression by focal cerebral ischemia is protease-dependent. J. Cereb. Blood Flow Metab. 28: 812-823